Vertex Pharmaceuticals Operating Expenses 2010-2024 | VRTX
Vertex Pharmaceuticals operating expenses for the twelve months ending December 31, 2024 were $11.253B, a 86.39% increase year-over-year.
- Vertex Pharmaceuticals annual operating expenses for 2024 were $11.253B, a 86.39% increase from 2023.
- Vertex Pharmaceuticals annual operating expenses for 2023 were $6.037B, a 30.58% increase from 2022.
- Vertex Pharmaceuticals annual operating expenses for 2022 were $4.623B, a 3.53% decline from 2021.